SEP-786 is an oral small molecule agonist of the parathyroid hormone 1 receptor (PTH1R) being developed for the treatment of hypoparathyroidism. Septerna’s decision follows the observation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback